471 related articles for article (PubMed ID: 32590316)
21. Mechanisms of immune evasion in breast cancer.
Bates JP; Derakhshandeh R; Jones L; Webb TJ
BMC Cancer; 2018 May; 18(1):556. PubMed ID: 29751789
[TBL] [Abstract][Full Text] [Related]
22. Tumor escape from immune response: mechanisms and targets of activity.
Gabrilovich D; Pisarev V
Curr Drug Targets; 2003 Oct; 4(7):525-36. PubMed ID: 14535653
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
24. Tumor plasticity interferes with anti-tumor immunity.
Chouaib S; Janji B; Tittarelli A; Eggermont A; Thiery JP
Crit Rev Immunol; 2014; 34(2):91-102. PubMed ID: 24940910
[TBL] [Abstract][Full Text] [Related]
25. Immune metabolism in PD-1 blockade-based cancer immunotherapy.
Kumar A; Chamoto K
Int Immunol; 2021 Jan; 33(1):17-26. PubMed ID: 32622347
[TBL] [Abstract][Full Text] [Related]
26. Elements of cancer immunity and the cancer-immune set point.
Chen DS; Mellman I
Nature; 2017 Jan; 541(7637):321-330. PubMed ID: 28102259
[TBL] [Abstract][Full Text] [Related]
27. Vaccines for established cancer: overcoming the challenges posed by immune evasion.
van der Burg SH; Arens R; Ossendorp F; van Hall T; Melief CJ
Nat Rev Cancer; 2016 Apr; 16(4):219-33. PubMed ID: 26965076
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapy.
Devillier R; Chrétien AS; Pagliardini T; Salem N; Blaise D; Olive D
J Leukoc Biol; 2021 Jun; 109(6):1071-1088. PubMed ID: 32991746
[TBL] [Abstract][Full Text] [Related]
29. Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer.
Cifaldi L; Di Santo J; Olive D
Front Immunol; 2020; 11():1132. PubMed ID: 32612604
[No Abstract] [Full Text] [Related]
30. Role of autophagy on cancer immune escape.
Duan Y; Tian X; Liu Q; Jin J; Shi J; Hou Y
Cell Commun Signal; 2021 Sep; 19(1):91. PubMed ID: 34493296
[TBL] [Abstract][Full Text] [Related]
31. Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets.
Reva BA; Omelchenko T; Nair SS; Tewari AK
Urol Clin North Am; 2020 Nov; 47(4S):e9-e16. PubMed ID: 33446324
[TBL] [Abstract][Full Text] [Related]
32. Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.
Gajewski TF; Corrales L; Williams J; Horton B; Sivan A; Spranger S
Adv Exp Med Biol; 2017; 1036():19-31. PubMed ID: 29275462
[TBL] [Abstract][Full Text] [Related]
33. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.
Jiang X; Wang J; Deng X; Xiong F; Ge J; Xiang B; Wu X; Ma J; Zhou M; Li X; Li Y; Li G; Xiong W; Guo C; Zeng Z
Mol Cancer; 2019 Jan; 18(1):10. PubMed ID: 30646912
[TBL] [Abstract][Full Text] [Related]
34. How Tumor Cell Dedifferentiation Drives Immune Evasion and Resistance to Immunotherapy.
Li J; Stanger BZ
Cancer Res; 2020 Oct; 80(19):4037-4041. PubMed ID: 32554552
[TBL] [Abstract][Full Text] [Related]
35. Strategies of tumor immune evasion.
Seliger B
BioDrugs; 2005; 19(6):347-54. PubMed ID: 16392887
[TBL] [Abstract][Full Text] [Related]
36. Immune checkpoint inhibitors: The linchpins of modern immunotherapy.
Wilky BA
Immunol Rev; 2019 Jul; 290(1):6-23. PubMed ID: 31355494
[TBL] [Abstract][Full Text] [Related]
37. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
De Jaeghere EA; Denys HG; De Wever O
Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
[TBL] [Abstract][Full Text] [Related]
38. Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?
Malmberg KJ
Cancer Immunol Immunother; 2004 Oct; 53(10):879-92. PubMed ID: 15338206
[TBL] [Abstract][Full Text] [Related]
39. Acquired resistance to cancer immunotherapy.
Draghi A; Chamberlain CA; Furness A; Donia M
Semin Immunopathol; 2019 Jan; 41(1):31-40. PubMed ID: 29968044
[TBL] [Abstract][Full Text] [Related]
40. Interferon gamma in cancer immunotherapy.
Ni L; Lu J
Cancer Med; 2018 Sep; 7(9):4509-4516. PubMed ID: 30039553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
